-
1
-
-
33751419875
-
Nanomedicine: Developing smarter therapeutic and diagnostic modalities
-
Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 2006, 58, 1456-1459.
-
(2006)
Adv. Drug Deliv. Rev
, vol.58
, pp. 1456-1459
-
-
Farokhzad, O.C.1
Langer, R.2
-
2
-
-
34247475688
-
Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
-
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 2007, 120, 2527-2537.
-
(2007)
Int. J. Cancer
, vol.120
, pp. 2527-2537
-
-
Liu, Y.1
Miyoshi, H.2
Nakamura, M.3
-
3
-
-
14644439267
-
Cancer nanotechnology: Opportunities and challenges
-
Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 161-171
-
-
Ferrari, M.1
-
4
-
-
4444379133
-
Nanoparticle and targeted systems for cancer therapy
-
Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004, 56, 1649-1659.
-
(2004)
Adv. Drug Deliv. Rev
, vol.56
, pp. 1649-1659
-
-
Brannon-Peppas, L.1
Blanchette, J.O.2
-
5
-
-
33646245291
-
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
-
Kawasaki ES, Player A. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 2005, 1, 101-109.
-
(2005)
Nanomedicine
, vol.1
, pp. 101-109
-
-
Kawasaki, E.S.1
Player, A.2
-
7
-
-
0035253404
-
Drug-targeting strategies in cancer therapy
-
Huang PS, Oliff A. Drug-targeting strategies in cancer therapy. Curr. Opin. Genet. Dev. 2001, 11, 104-110.
-
(2001)
Curr. Opin. Genet. Dev
, vol.11
, pp. 104-110
-
-
Huang, P.S.1
Oliff, A.2
-
8
-
-
0344494508
-
Advancing the fi eld of drug delivery: Taking aim at cancer
-
Moses MA, Brem H, Langer R. Advancing the fi eld of drug delivery: taking aim at cancer. Cancer Cell 2003, 4, 337-341.
-
(2003)
Cancer Cell
, vol.4
, pp. 337-341
-
-
Moses, M.A.1
Brem, H.2
Langer, R.3
-
9
-
-
14044261316
-
What ' s wrong with our cancer models ?
-
Kamb A. What ' s wrong with our cancer models ? Nat. Rev. Drug Discov. 2005, 4, 161-165.
-
(2005)
Nat. Rev. Drug Discov
, vol.4
, pp. 161-165
-
-
Kamb, A.1
-
10
-
-
11144242211
-
Timeline: Chemotherapy and the war on cancer
-
Chabner BA, Roberts TG Jr. Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 2005, 5, 65-72.
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 65-72
-
-
Chabner, B.A.1
Roberts, T.G.2
-
11
-
-
0036629179
-
Nanostructures as tailored biological probes
-
Taton TA. Nanostructures as tailored biological probes. Trends Biotechnol. 2002, 20, 277-279.
-
(2002)
Trends Biotechnol
, vol.20
, pp. 277-279
-
-
Taton, T.A.1
-
12
-
-
0037503818
-
Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus
-
Raja KS, Wang Q, Gonzalez MJ, Manchester M, Johnson JE, Finn MG. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules 2003, 4, 472-476.
-
(2003)
Biomacromolecules
, vol.4
, pp. 472-476
-
-
Raja, K.S.1
Wang, Q.2
Gonzalez, M.J.3
Manchester, M.4
Johnson, J.E.5
Finn, M.G.6
-
13
-
-
33646421669
-
Covalently linked Au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy
-
Everts M, Saini V, Leddon JL, Kok RJ, Stoff-Khalili M, Preuss MA, Millican CL, Perkins G, Brown JM, Bagaria H, Nikles DE, Johnson DT, Zharov VP, Curiel DT. Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett. 2006, 6, 587-591.
-
(2006)
Nano Lett
, vol.6
, pp. 587-591
-
-
Everts, M.1
Saini, V.2
Leddon, J.L.3
Kok, R.J.4
Stoff-Khalili, M.5
Preuss, M.A.6
Millican, C.L.7
Perkins, G.8
Brown, J.M.9
Bagaria, H.10
Nikles, D.E.11
Johnson, D.T.12
Zharov, V.P.13
Curiel, D.T.14
-
14
-
-
32544436574
-
Nano-oncology: Drug delivery, imaging, and sensing
-
Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 2006, 384, 620-630.
-
(2006)
Anal. Bioanal. Chem
, vol.384
, pp. 620-630
-
-
Portney, N.G.1
Ozkan, M.2
-
15
-
-
0038387390
-
The dawning era of polymer therapeutics
-
Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2003, 2, 347-360.
-
(2003)
Nat. Rev. Drug Discov
, vol.2
, pp. 347-360
-
-
Duncan, R.1
-
16
-
-
0032552819
-
Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy
-
Nashat AH, Moronne M, Ferrari M. Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy. Biotechnol. Bioeng. 1998, 60, 137-146.
-
(1998)
Biotechnol. Bioeng
, vol.60
, pp. 137-146
-
-
Nashat, A.H.1
Moronne, M.2
Ferrari, M.3
-
17
-
-
17144417434
-
A theoretical model for the margination of particles within blood vessels
-
Decuzzi P, Lee S, Bhushan B, Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 2005, 33, 179-190.
-
(2005)
Ann. Biomed. Eng
, vol.33
, pp. 179-190
-
-
Decuzzi, P.1
Lee, S.2
Bhushan, B.3
Ferrari, M.4
-
18
-
-
0028849284
-
Time-dependent behavior of interstitial fl uid pressure in solid tumors: Implications for drug delivery
-
Netti PA, Baxter LT, Boucher Y, Skalak R, Jain RK. Time-dependent behavior of interstitial fl uid pressure in solid tumors: implications for drug delivery. Cancer Res. 1995, 55, 5451-5458.
-
(1995)
Cancer Res
, vol.55
, pp. 5451-5458
-
-
Netti, P.A.1
Baxter, L.T.2
Boucher, Y.3
Skalak, R.4
Jain, R.K.5
-
19
-
-
0036096806
-
Liposome-based drug delivery in breast cancer treatment
-
Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 2002, 4, 95-99.
-
(2002)
Breast Cancer Res
, vol.4
, pp. 95-99
-
-
Park, J.W.1
-
20
-
-
0025981079
-
Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of lipo-somes depends on the liposome size and is unfavorable for immunoliposome binding to target
-
Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of lipo-somes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991, 1062, 142-148.
-
(1991)
Biochim. Biophys. Acta
, vol.1062
, pp. 142-148
-
-
Klibanov, A.L.1
Maruyama, K.2
Beckerleg, A.M.3
Torchilin, V.P.4
Huang, L.5
-
21
-
-
0037184446
-
Designing macromolecules for therapeutic applications: Polyester dendrimer-poly(ethylene oxide) bow-tie hybrids with tunable molecular weight and architecture
-
Gillies ER, Frechet JMJ. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) bow-tie hybrids with tunable molecular weight and architecture. J. Am. Chem. Soc. 2002, 124, 14137-14146.
-
(2002)
J. Am. Chem. Soc
, vol.124
, pp. 14137-14146
-
-
Gillies, E.R.1
Frechet, J.M.J.2
-
22
-
-
0027180686
-
Block-copolymer micelles as vehicles for drug delivery
-
Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block-copolymer micelles as vehicles for drug delivery. J. Control. Rel. 1993, 24, 119-132.
-
(1993)
J. Control. Rel
, vol.24
, pp. 119-132
-
-
Kataoka, K.1
Kwon, G.S.2
Yokoyama, M.3
Okano, T.4
Sakurai, Y.5
-
23
-
-
63349090588
-
Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain
-
Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G. Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain. Curr. Top. Med. Chem. 2009, 9, 182-196.
-
(2009)
Curr. Top. Med. Chem
, vol.9
, pp. 182-196
-
-
Denora, N.1
Trapani, A.2
Laquintana, V.3
Lopedota, A.4
Trapani, G.5
-
24
-
-
0346848865
-
Nanotech approaches to drug delivery and imaging
-
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 2003, 8, 1112-1120.
-
(2003)
Drug Discov. Today
, vol.8
, pp. 1112-1120
-
-
Sahoo, S.K.1
Labhasetwar, V.2
-
25
-
-
12344262085
-
Drug transport to brain with targeted liposomes
-
Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx 2005, 2, 99-107.
-
(2005)
NeuroRx
, vol.2
, pp. 99-107
-
-
Schnyder, A.1
Huwyler, J.2
-
26
-
-
14144250911
-
Recent advances with liposomes as pharmaceutical carriers
-
Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4, 145-160.
-
(2005)
Nat. Rev. Drug Discov
, vol.4
, pp. 145-160
-
-
Torchilin, V.P.1
-
27
-
-
0141927263
-
Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties
-
Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42, 463-478.
-
(2003)
Prog. Lipid Res
, vol.42
, pp. 463-478
-
-
Moghimi, S.M.1
Szebeni, J.2
-
28
-
-
77955466238
-
Nanoparticle-mediated brain-specifi c drug delivery, imaging, and diagnosis
-
Yang H. Nanoparticle-mediated brain-specifi c drug delivery, imaging, and diagnosis. Pharm. Res. 2010, 27, 1759-1771.
-
(2010)
Pharm. Res
, vol.27
, pp. 1759-1771
-
-
Yang, H.1
-
29
-
-
77953912416
-
Strategy for effective brain drug delivery
-
Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M. Strategy for effective brain drug delivery. Eur. J. Pharm. Sci. 2010, 40, 385-403.
-
(2010)
Eur. J. Pharm. Sci
, vol.40
, pp. 385-403
-
-
Alam, M.I.1
Beg, S.2
Samad, A.3
Baboota, S.4
Kohli, K.5
Ali, J.6
Ahuja, A.7
Akbar, M.8
-
30
-
-
0034992134
-
Trends and developments in liposome drug delivery systems
-
Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001, 90, 667-680.
-
(2001)
J. Pharm. Sci
, vol.90
, pp. 667-680
-
-
Lian, T.1
Ho, R.J.2
-
31
-
-
0028222291
-
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
-
Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 1994, 15, 215-220.
-
(1994)
Trends Pharmacol. Sci
, vol.15
, pp. 215-220
-
-
Allen, T.M.1
-
32
-
-
0026509831
-
Blood-brain barrier and new approaches to brain drug delivery
-
Pardridge WM, Boado RJ, Black KL, Cancilla PA. Blood-brain barrier and new approaches to brain drug delivery. West J. Med. 1992, 156, 281-286.
-
(1992)
West J. Med
, vol.156
, pp. 281-286
-
-
Pardridge, W.M.1
Boado, R.J.2
Black, K.L.3
Cancilla, P.A.4
-
33
-
-
69249217640
-
Biomaterials for promoting brain protection, repair and regeneration
-
Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 2009, 10, 682-692.
-
(2009)
Nat. Rev. Neurosci
, vol.10
, pp. 682-692
-
-
Orive, G.1
Anitua, E.2
Pedraz, J.L.3
Emerich, D.F.4
-
34
-
-
33646685202
-
Delivery strategies for siRNA-mediated gene silencing
-
Gilmore IR, Fox SP, Hollins AJ, Akhtar S. Delivery strategies for siRNA-mediated gene silencing. Curr. Drug Deliv. 2006, 3, 147-155.
-
(2006)
Curr. Drug Deliv
, vol.3
, pp. 147-155
-
-
Gilmore, I.R.1
Fox, S.P.2
Hollins, A.J.3
Akhtar, S.4
-
35
-
-
34248672837
-
Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specifi city
-
Akhtar S, Benter I. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specifi city. Adv. Drug Deliv. Rev. 2007, 59, 164-182.
-
(2007)
Adv. Drug Deliv. Rev
, vol.59
, pp. 164-182
-
-
Akhtar, S.1
Benter, I.2
-
37
-
-
80054756400
-
Multistage nanovectors: From concept to novel imaging contrast agents and therapeutics
-
Godin B, Tasciotti E, Liu X, Serda RE, Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res. 2011, 44, 979-989.
-
(2011)
Acc. Chem. Res
, vol.44
, pp. 979-989
-
-
Godin, B.1
Tasciotti, E.2
Liu, X.3
Serda, R.E.4
Ferrari, M.5
-
38
-
-
33646185371
-
RNAi-mediated gene silencing in non-human primates
-
Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M, Judge AD, Lam K, McClintock K, Nechev LV, Palmer LR, Racie T, Rohl I, Seiffert S, Shanmugam S, Sood V, Soutschek J, Toudjarska I, Wheat AJ, Yaworski E, Zedalis W, Koteliansky V, Manoharan M, Vornlocher HP, MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 2006, 441, 111-114.
-
(2006)
Nature
, vol.441
, pp. 111-114
-
-
Zimmermann, T.S.1
Lee, A.C.2
Akinc, A.3
Bramlage, B.4
Bumcrot, D.5
Fedoruk, M.N.6
Harborth, J.7
Heyes, J.A.8
Jeffs, L.B.9
John, M.10
Judge, A.D.11
Lam, K.12
McClintock, K.13
Nechev, L.V.14
Palmer, L.R.15
Racie, T.16
Rohl, I.17
Seiffert, S.18
Shanmugam, S.19
Sood, V.20
Soutschek, J.21
Toudjarska, I.22
Wheat, A.J.23
Yaworski, E.24
Zedalis, W.25
Koteliansky, V.26
Manoharan, M.27
Vornlocher, H.P.28
MacLachlan, I.29
more..
-
39
-
-
43049176170
-
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
-
Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, Borodovsky A, Borland T, Constien R, de Fougerolles A, Dorkin JR, Narayanannair Jayaprakash K, Jayaraman M, John M, Koteliansky V, Manoharan M, Nechev L, Qin J, Racie T, Raitcheva D, Rajeev KG, Sah DW, Soutschek J, Toudjarska I, Vornlocher HP, Zimmermann TS, Langer R, Anderson DG. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 2008, 26, 561-569.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 561-569
-
-
Akinc, A.1
Zumbuehl, A.2
Goldberg, M.3
Leshchiner, E.S.4
Busini, V.5
Hossain, N.6
Bacallado, S.A.7
Nguyen, D.N.8
Fuller, J.9
Alvarez, R.10
Borodovsky, A.11
Borland, T.12
Constien, R.13
De Fougerolles, A.14
Dorkin, J.R.15
Narayanannair Jayaprakash, K.16
Jayaraman, M.17
John, M.18
Koteliansky, V.19
Manoharan, M.20
Nechev, L.21
Qin, J.22
Racie, T.23
Raitcheva, D.24
Rajeev, K.G.25
Sah, D.W.26
Soutschek, J.27
Toudjarska, I.28
Vornlocher, H.P.29
Zimmermann, T.S.30
Langer, R.31
Anderson, D.G.32
more..
-
40
-
-
50149101511
-
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
-
Frank-Kamenetsky M, Grefhorst A, Anderson NN, Racie TS, Bramlage B, Akinc A, Butler D, Charisse K, Dorkin R, Fan Y, Gamba-Vitalo C, Hadwiger P, Jayaraman M, John M, Jayaprakash KN, Maier M, Nechev L, Rajeev KG, Read T, Rohl I, Soutschek J, Tan P, Wong J, Wang G, Zimmermann T, de Fougerolles A, Vornlocher HP, Langer R, Anderson DG, Manoharan M, Koteliansky V, Horton JD, Fitzgerald K. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl. Acad. Sci. USA 2008, 105, 11915-11920.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 11915-11920
-
-
Frank-Kamenetsky, M.1
Grefhorst, A.2
Anderson, N.N.3
Racie, T.S.4
Bramlage, B.5
Akinc, A.6
Butler, D.7
Charisse, K.8
Dorkin, R.9
Fan, Y.10
Gamba-Vitalo, C.11
Hadwiger, P.12
Jayaraman, M.13
John, M.14
Jayaprakash, K.N.15
Maier, M.16
Nechev, L.17
Rajeev, K.G.18
Read, T.19
Rohl, I.20
Soutschek, J.21
Tan, P.22
Wong, J.23
Wang, G.24
Zimmermann, T.25
De Fougerolles, A.26
Vornlocher, H.P.27
Langer, R.28
Anderson, D.G.29
Manoharan, M.30
Koteliansky, V.31
Horton, J.D.32
Fitzgerald, K.33
more..
-
41
-
-
41849117310
-
Resolution of liver cirrhosis using Vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
-
Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, Takimoto R, Takada K, Miyanishi K, Matsunaga T, Takayama T, Niitsu Y. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 2008, 26, 431-442.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 431-442
-
-
Sato, Y.1
Murase, K.2
Kato, J.3
Kobune, M.4
Sato, T.5
Kawano, Y.6
Takimoto, R.7
Takada, K.8
Miyanishi, K.9
Matsunaga, T.10
Takayama, T.11
Niitsu, Y.12
-
42
-
-
33645720317
-
Postexposure protection of Guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference
-
Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JR, Lee AC, Judge A, Jeffs LB, MacLachlan I. Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 2006, 193, 1650-1657.
-
(2006)
J. Infect. Dis
, vol.193
, pp. 1650-1657
-
-
Geisbert, T.W.1
Hensley, L.E.2
Kagan, E.3
Yu, E.Z.4
Geisbert, J.B.5
Daddario-DiCaprio, K.6
Fritz, E.A.7
Jahrling, P.B.8
McClintock, K.9
Phelps, J.R.10
Lee, A.C.11
Judge, A.12
Jeffs, L.B.13
MacLachlan, I.14
-
43
-
-
38349036163
-
MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion
-
Yamada Y, Akita H, Kamiya H, Kogure K, Yamamoto T, Shinohara Y, Yamashita K, Kobayashi H, Kikuchi H, Harashima H. MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim. Biophys. Acta 2008, 1778, 423-432.
-
(2008)
Biochim. Biophys. Acta
, vol.1778
, pp. 423-432
-
-
Yamada, Y.1
Akita, H.2
Kamiya, H.3
Kogure, K.4
Yamamoto, T.5
Shinohara, Y.6
Yamashita, K.7
Kobayashi, H.8
Kikuchi, H.9
Harashima, H.10
-
44
-
-
77955480347
-
Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes
-
Yasuzaki Y, Yamada Y, Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem. Biophys. Res. Commun. 2010, 397, 181-186.
-
(2010)
Biochem. Biophys. Res. Commun
, vol.397
, pp. 181-186
-
-
Yasuzaki, Y.1
Yamada, Y.2
Harashima, H.3
-
45
-
-
79961023252
-
Dual function MITO-Porter, a nanocarrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery
-
Yamada Y, Furukawa R, Yasuzaki Y, Harashima H. Dual function MITO-Porter, a nanocarrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol. Ther. 2011, 19, 1449-1456.
-
(2011)
Mol. Ther
, vol.19
, pp. 1449-1456
-
-
Yamada, Y.1
Furukawa, R.2
Yasuzaki, Y.3
Harashima, H.4
-
46
-
-
83555164614
-
Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter
-
Yamada Y, Harashima H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, 33, 1589-1595.
-
(2012)
Biomaterials
, vol.33
, pp. 1589-1595
-
-
Yamada, Y.1
Harashima, H.2
-
47
-
-
0028310282
-
Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism
-
McRae A, Dahlstrom A. Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism. Neurochem. Int. 1994, 25, 27-33.
-
(1994)
Neurochem. Int
, vol.25
, pp. 27-33
-
-
McRae, A.1
Dahlstrom, A.2
-
48
-
-
0035946615
-
Solid lipid nanoparticles: Production, characterization and applications
-
Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47, 165-196.
-
(2001)
Adv. Drug Deliv. Rev
, vol.47
, pp. 165-196
-
-
Mehnert, W.1
Mader, K.2
-
49
-
-
34547871312
-
Solid lipid nanoparticles for targeted brain drug delivery
-
Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 454-477.
-
(2007)
Adv. Drug Deliv. Rev
, vol.59
, pp. 454-477
-
-
Blasi, P.1
Giovagnoli, S.2
Schoubben, A.3
Ricci, M.4
Rossi, C.5
-
50
-
-
41449091856
-
Potential of solid lipid nanoparticles in brain targeting
-
Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J. Control. Rel. 2008, 127, 97-109.
-
(2008)
J. Control. Rel
, vol.127
, pp. 97-109
-
-
Kaur, I.P.1
Bhandari, R.2
Bhandari, S.3
Kakkar, V.4
-
51
-
-
34249079979
-
Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors ?
-
Brioschi A, Zenga F, Zara GP, Gasco MR, Ducati A, Mauro A. Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors ? Neurol. Res. 2007, 29, 324-330.
-
(2007)
Neurol. Res
, vol.29
, pp. 324-330
-
-
Brioschi, A.1
Zenga, F.2
Zara, G.P.3
Gasco, M.R.4
Ducati, A.5
Mauro, A.6
-
52
-
-
51749096415
-
Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line
-
Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 2008, 25, 2262-2271.
-
(2008)
Pharm. Res
, vol.25
, pp. 2262-2271
-
-
Chattopadhyay, N.1
Zastre, J.2
Wong, H.L.3
Wu, X.Y.4
Bendayan, R.5
-
53
-
-
51049101925
-
Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA
-
Kim HR, Kim IK, Bae KH, Lee SH, Lee Y, Park TG. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol. Pharm. 2008, 5, 622-631.
-
(2008)
Mol. Pharm
, vol.5
, pp. 622-631
-
-
Kim, H.R.1
Kim, I.K.2
Bae, K.H.3
Lee, S.H.4
Lee, Y.5
Park, T.G.6
-
54
-
-
84555223589
-
In vivo sustained release of siRNA from solid lipid nanoparticles
-
Lobovkina T, Jacobson GB, Gonzalez-Gonzalez E, Hickerson RP, Leake D, Kaspar RL, Contag CH, Zare RN. In vivo sustained release of siRNA from solid lipid nanoparticles. ACS Nano 2011, 5, 9977-9983.
-
(2011)
ACS Nano
, vol.5
, pp. 9977-9983
-
-
Lobovkina, T.1
Jacobson, G.B.2
Gonzalez-Gonzalez, E.3
Hickerson, R.P.4
Leake, D.5
Kaspar, R.L.6
Contag, C.H.7
Zare, R.N.8
-
55
-
-
84856619472
-
Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA
-
Yu YH, Kim E, Park DE, Shim G, Lee S, Kim YB, Kim CW, Oh YK. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur. J. Pharm. Biopharm. 2012, 80, 268-273.
-
(2012)
Eur. J. Pharm. Biopharm
, vol.80
, pp. 268-273
-
-
Yu, Y.H.1
Kim, E.2
Park, D.E.3
Shim, G.4
Lee, S.5
Kim, Y.B.6
Kim, C.W.7
Oh, Y.K.8
-
56
-
-
84555220669
-
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles
-
Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam DH. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconj. Chem. 2011, 22, 2568-2572.
-
(2011)
Bioconj. Chem
, vol.22
, pp. 2568-2572
-
-
Jin, J.1
Bae, K.H.2
Yang, H.3
Lee, S.J.4
Kim, H.5
Kim, Y.6
Joo, K.M.7
Seo, S.W.8
Park, T.G.9
Nam, D.H.10
-
57
-
-
0036205158
-
Nanoparticle technology for drug delivery across the blood-brain barrier
-
Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 2002, 28, 1-13.
-
(2002)
Drug Dev. Ind. Pharm
, vol.28
, pp. 1-13
-
-
Lockman, P.R.1
Mumper, R.J.2
Khan, M.A.3
Allen, D.D.4
-
58
-
-
47649114017
-
Biomaterials for the central nervous system
-
Zhong Y, Bellamkonda RV. Biomaterials for the central nervous system. J. R. Soc. Interface 2008, 5, 957-975.
-
(2008)
J. R. Soc. Interface
, vol.5
, pp. 957-975
-
-
Zhong, Y.1
Bellamkonda, R.V.2
-
59
-
-
33751419974
-
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing
-
Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007, 28, 1280-1288.
-
(2007)
Biomaterials
, vol.28
, pp. 1280-1288
-
-
Liu, X.1
Howard, K.A.2
Dong, M.3
Andersen, M.O.4
Rahbek, U.L.5
Johnsen, M.G.6
Hansen, O.C.7
Besenbacher, F.8
Kjems, J.9
-
60
-
-
0037335187
-
Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specifi c mechanisms requiring prior binding of drug to the nanoparticles
-
Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specifi c mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 2003, 20, 409-416.
-
(2003)
Pharm. Res
, vol.20
, pp. 409-416
-
-
Kreuter, J.1
Ramge, P.2
Petrov, V.3
Hamm, S.4
Gelperina, S.E.5
Engelhardt, B.6
Alyautdin, R.7
Von Briesen, H.8
Begley, D.J.9
-
61
-
-
77952484431
-
The role of surface functionalization in the design of PLGA micro-and nanoparticles
-
Ratzinger G, Fillafer C, Kerleta V, Wirth M, Gabor F. The role of surface functionalization in the design of PLGA micro-and nanoparticles. Crit. Rev. Ther. Drug Carrier Syst. 2010, 27, 1-83.
-
(2010)
Crit. Rev. Ther. Drug Carrier Syst
, vol.27
, pp. 1-83
-
-
Ratzinger, G.1
Fillafer, C.2
Kerleta, V.3
Wirth, M.4
Gabor, F.5
-
62
-
-
48449094740
-
Poly(lacticco-glycolic acid) nanospheres and microspheres for short-and long-term delivery of bioactive ciliary neurotrophic factor
-
Nkansah MK, Tzeng SY, Holdt AM, Lavik EB. Poly(lacticco-glycolic acid) nanospheres and microspheres for short-and long-term delivery of bioactive ciliary neurotrophic factor. Biotechnol. Bioeng. 2008, 100, 1010-1019.
-
(2008)
Biotechnol. Bioeng
, vol.100
, pp. 1010-1019
-
-
Nkansah, M.K.1
Tzeng, S.Y.2
Holdt, A.M.3
Lavik, E.B.4
-
63
-
-
84856755816
-
Pilocarpineloaded poly(DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response
-
Nair KL, Vidyanand S, James J, Kumar GSV. Pilocarpineloaded poly(DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response. J. Appl. Polym. Sci. 2012, 124, 2030-2036.
-
(2012)
J. Appl. Polym. Sci
, vol.124
, pp. 2030-2036
-
-
Nair, K.L.1
Vidyanand, S.2
James, J.3
Kumar, G.S.V.4
-
64
-
-
0021349643
-
Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image
-
Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res. 1984, 44, 2115-2121.
-
(1984)
Cancer Res
, vol.44
, pp. 2115-2121
-
-
Iwai, K.1
Maeda, H.2
Konno, T.3
-
65
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumori-tropic accumulation of proteins and the antitumor agent SMANCs
-
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumori-tropic accumulation of proteins and the antitumor agent SMANCs. Cancer Res. 1986, 46, 6387-6392.
-
(1986)
Cancer Res
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
66
-
-
0037124546
-
The origin of pegnology
-
Davis FF. The origin of pegnology. Adv. Drug Deliv. Rev. 2002, 54, 457-458.
-
(2002)
Adv. Drug Deliv. Rev
, vol.54
, pp. 457-458
-
-
Davis, F.F.1
-
67
-
-
0025028357
-
Efficacy of once-a-day terazosin in benign prostatic hyperplasia: A randomized, double-blind placebo-controlled clinical trial
-
Fabricius PG, Weizert P, Dunzendorfer U, Hannaford JM, Maurath C. Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial. Prostate Suppl. 1990, 3, 85-93.
-
(1990)
Prostate Suppl
, vol.3
, pp. 85-93
-
-
Fabricius, P.G.1
Weizert, P.2
Dunzendorfer, U.3
Hannaford, J.M.4
Maurath, C.5
-
68
-
-
0042999388
-
Pegaspargase: A review of clinical studies
-
Graham ML. Pegaspargase: a review of clinical studies. Adv. Drug Deliv. Rev. 2003, 55, 1293-1302.
-
(2003)
Adv. Drug Deliv. Rev
, vol.55
, pp. 1293-1302
-
-
Graham, M.L.1
-
69
-
-
0029160083
-
Lezoualc ' h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
-
Boussif O, Lezoualc ' h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 1995, 92, 7297-7301.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 7297-7301
-
-
Boussif, O.1
-
70
-
-
33744805790
-
Polymers for gene delivery across length scales
-
Putnam D. Polymers for gene delivery across length scales. Nat. Mater. 2006, 5, 439-451.
-
(2006)
Nat. Mater
, vol.5
, pp. 439-451
-
-
Putnam, D.1
-
71
-
-
20444377785
-
Polyethylenimine-based non-viral gene delivery systems
-
Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 2005, 60, 247-266.
-
(2005)
Eur. J. Pharm. Biopharm
, vol.60
, pp. 247-266
-
-
Lungwitz, U.1
Breunig, M.2
Blunk, T.3
Gopferich, A.4
-
72
-
-
47749100430
-
Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity
-
Zintchenko A, Philipp A, Dehshahri A, Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconj. Chem. 2008, 19, 1448-1455.
-
(2008)
Bioconj. Chem
, vol.19
, pp. 1448-1455
-
-
Zintchenko, A.1
Philipp, A.2
Dehshahri, A.3
Wagner, E.4
-
73
-
-
12344291244
-
Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers
-
Zhu J, Tang A, Law LP, Feng M, Ho KM, Lee DK, Harris FW, Li P. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Bioconj. Chem. 2005, 16, 139-146.
-
(2005)
Bioconj. Chem
, vol.16
, pp. 139-146
-
-
Zhu, J.1
Tang, A.2
Law, L.P.3
Feng, M.4
Ho, K.M.5
Lee, D.K.6
Harris, F.W.7
Li, P.8
-
74
-
-
77951159570
-
The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro
-
Wu Y, Wang W, Chen Y, Huang K, Shuai X, Chen Q, Li X, Lian G. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. Int. J. Nanomed. 2010, 5, 129-136.
-
(2010)
Int. J. Nanomed
, vol.5
, pp. 129-136
-
-
Wu, Y.1
Wang, W.2
Chen, Y.3
Huang, K.4
Shuai, X.5
Chen, Q.6
Li, X.7
Lian, G.8
-
75
-
-
84857917025
-
Polyethyleneimine-based core-shell nanogels: A promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells
-
Mimi H, Ho KM, Siu YS, Wu A, Li P. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. J. Control. Rel. 2012, 158, 123-130.
-
(2012)
J. Control. Rel
, vol.158
, pp. 123-130
-
-
Mimi, H.1
Ho, K.M.2
Siu, Y.S.3
Wu, A.4
Li, P.5
-
76
-
-
80052850129
-
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
-
Sureban SM, May R, Mondalek FG, Qu D, Ponnurangam S, Pantazis P, Anant S, Ramanujam RP, Houchen CW. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J. Nanobiotechnol. 2011, 9, 40.
-
(2011)
J. Nanobiotechnol
, vol.9
, pp. 40
-
-
Sureban, S.M.1
May, R.2
Mondalek, F.G.3
Qu, D.4
Ponnurangam, S.5
Pantazis, P.6
Anant, S.7
Ramanujam, R.P.8
Houchen, C.W.9
-
77
-
-
67649229657
-
Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers
-
Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Deliv. Rev. 2009, 61, 768-784.
-
(2009)
Adv. Drug Deliv. Rev
, vol.61
, pp. 768-784
-
-
Bae, Y.1
Kataoka, K.2
-
78
-
-
34250770499
-
Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation
-
Akagi D, Oba M, Koyama H, Nishiyama N, Fukushima S, Miyata T, Nagawa H, Kataoka K. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. Gene Ther. 2007, 14, 1029-1038.
-
(2007)
Gene Ther
, vol.14
, pp. 1029-1038
-
-
Akagi, D.1
Oba, M.2
Koyama, H.3
Nishiyama, N.4
Fukushima, S.5
Miyata, T.6
Nagawa, H.7
Kataoka, K.8
-
79
-
-
33845388144
-
Micellar nanocarriers: Pharmaceutical perspectives
-
Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 2007, 24, 1-16.
-
(2007)
Pharm. Res
, vol.24
, pp. 1-16
-
-
Torchilin, V.P.1
-
80
-
-
0035080570
-
Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers
-
Harada A, Togawa H, Kataoka K. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. Eur. J. Pharm. Sci. 2001, 13, 35-42.
-
(2001)
Eur. J. Pharm. Sci
, vol.13
, pp. 35-42
-
-
Harada, A.1
Togawa, H.2
Kataoka, K.3
-
81
-
-
34447632643
-
Angiogenesis in brain tumours
-
Jain RK, di Tomaso E, Duda DG, Loeffl er JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat. Rev. Neurosci. 2007, 8, 610-622.
-
(2007)
Nat. Rev. Neurosci
, vol.8
, pp. 610-622
-
-
Jain, R.K.1
Di Tomaso, E.2
Duda, D.G.3
Loeffl er, J.S.4
Sorensen, A.G.5
Batchelor, T.T.6
-
82
-
-
33644772618
-
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers
-
Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J. Natl. Cancer Inst. 2006, 98, 335-344.
-
(2006)
J. Natl. Cancer Inst
, vol.98
, pp. 335-344
-
-
Dreher, M.R.1
Liu, W.2
Michelich, C.R.3
Dewhirst, M.W.4
Yuan, F.5
Chilkoti, A.6
-
83
-
-
34247642609
-
Targeted nanoparticles for cancer therapy
-
Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S, Langer RS, Farokhzad OC. Targeted nanoparticles for cancer therapy. Nano Today 2007, 2, 14-21.
-
(2007)
Nano Today
, vol.2
, pp. 14-21
-
-
Gu, F.X.1
Karnik, R.2
Wang, A.Z.3
Alexis, F.4
Levy-Nissenbaum, E.5
Hong, S.6
Langer, R.S.7
Farokhzad, O.C.8
-
84
-
-
42349106952
-
Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates
-
Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer RS, Farokhzad OC. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chem. Med. Chem. 2007, 2, 1268-1271.
-
(2007)
Chem. Med. Chem
, vol.2
, pp. 1268-1271
-
-
Zhang, L.1
Radovic-Moreno, A.F.2
Alexis, F.3
Gu, F.X.4
Basto, P.A.5
Bagalkot, V.6
Jon, S.7
Langer, R.S.8
Farokhzad, O.C.9
-
85
-
-
0037338049
-
Liposomemediated targeting of enzymes to cancer cells for site-specifi c activation of prodrugs: Comparison with the corresponding antibody-enzyme conjugate
-
Fonseca MJ, Jagtenberg JC, Haisma HJ, Storm G. Liposomemediated targeting of enzymes to cancer cells for site-specifi c activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate. Pharm. Res. 2003, 20, 423-428.
-
(2003)
Pharm. Res
, vol.20
, pp. 423-428
-
-
Fonseca, M.J.1
Jagtenberg, J.C.2
Haisma, H.J.3
Storm, G.4
-
86
-
-
33646582037
-
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
-
Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 2006, 103, 6315-6320.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 6315-6320
-
-
Farokhzad, O.C.1
Cheng, J.2
Teply, B.A.3
Sherifi, I.4
Jon, S.5
Kantoff, P.W.6
Richie, J.P.7
Langer, R.8
-
87
-
-
0037151313
-
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery
-
Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Rel. 2002, 82, 189-212.
-
(2002)
J. Control. Rel
, vol.82
, pp. 189-212
-
-
Kabanov, A.V.1
Batrakova, E.V.2
Alakhov, V.Y.3
-
88
-
-
85047695467
-
Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer
-
Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K. Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther. 2002, 9, 407-414.
-
(2002)
Gene Ther
, vol.9
, pp. 407-414
-
-
Harada-Shiba, M.1
Yamauchi, K.2
Harada, A.3
Takamisawa, I.4
Shimokado, K.5
Kataoka, K.6
-
89
-
-
34548644167
-
Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life
-
Sato A, Choi SW, Hirai M, Yamayoshi A, Moriyama R, Yamano T, Takagi M, Kano A, Shimamoto A, Maruyama A. Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life. J. Control. Rel. 2007, 122, 209-216.
-
(2007)
J. Control. Rel
, vol.122
, pp. 209-216
-
-
Sato, A.1
Choi, S.W.2
Hirai, M.3
Yamayoshi, A.4
Moriyama, R.5
Yamano, T.6
Takagi, M.7
Kano, A.8
Shimamoto, A.9
Maruyama, A.10
-
90
-
-
58549112795
-
Environmentresponsive block copolymer micelles with a disulfide crosslinked core for enhanced siRNA delivery
-
Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, Koyama H, Yamasaki Y, Kataoka K. Environmentresponsive block copolymer micelles with a disulfide crosslinked core for enhanced siRNA delivery. Biomacromolecules 2009, 10, 119-127.
-
(2009)
Biomacromolecules
, vol.10
, pp. 119-127
-
-
Matsumoto, S.1
Christie, R.J.2
Nishiyama, N.3
Miyata, K.4
Ishii, A.5
Oba, M.6
Koyama, H.7
Yamasaki, Y.8
Kataoka, K.9
-
91
-
-
77950611468
-
SiRNA-based therapy ameliorates glomerulonephritis
-
Shimizu H, Hori Y, Kaname S, Yamada K, Nishiyama N, Matsumoto S, Miyata K, Oba M, Yamada A, Kataoka K, Fujita T. siRNA-based therapy ameliorates glomerulonephritis. J. Am. Soc. Nephrol. 2010, 21, 622-633.
-
(2010)
J. Am. Soc. Nephrol
, vol.21
, pp. 622-633
-
-
Shimizu, H.1
Hori, Y.2
Kaname, S.3
Yamada, K.4
Nishiyama, N.5
Matsumoto, S.6
Miyata, K.7
Oba, M.8
Yamada, A.9
Kataoka, K.10
Fujita, T.11
-
92
-
-
10844293438
-
Phase i clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
-
Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 2004, 91, 1775-1781.
-
(2004)
Br. J. Cancer
, vol.91
, pp. 1775-1781
-
-
Matsumura, Y.1
Hamaguchi, T.2
Ura, T.3
Muro, K.4
Yamada, Y.5
Shimada, Y.6
Shirao, K.7
Okusaka, T.8
Ueno, H.9
Ikeda, M.10
Watanabe, N.11
-
93
-
-
34447331464
-
A phase i and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nano-particle formulation
-
Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, Muro K, Yamada Y, Okusaka T, Shirao K, Shimada Y, Nakahama H, Matsumura Y. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nano-particle formulation. Br. J. Cancer 2007, 97, 170-176.
-
(2007)
Br. J. Cancer
, vol.97
, pp. 170-176
-
-
Hamaguchi, T.1
Kato, K.2
Yasui, H.3
Morizane, C.4
Ikeda, M.5
Ueno, H.6
Muro, K.7
Yamada, Y.8
Okusaka, T.9
Shirao, K.10
Shimada, Y.11
Nakahama, H.12
Matsumura, Y.13
-
94
-
-
38549180565
-
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier
-
Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC, Ling EA, Moochhala S, Yang YY. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 2008, 29, 1509-1517.
-
(2008)
Biomaterials
, vol.29
, pp. 1509-1517
-
-
Liu, L.1
Guo, K.2
Lu, J.3
Venkatraman, S.S.4
Luo, D.5
Ng, K.C.6
Ling, E.A.7
Moochhala, S.8
Yang, Y.Y.9
-
96
-
-
0030460361
-
Chemotherapy in the management of patients with inoperable non-small cell lung cancer
-
Carney DN. Chemotherapy in the management of patients with inoperable non-small cell lung cancer. Semin. Oncol. 1996, 23(Suppl. 16), 71-75.
-
(1996)
Semin. Oncol
, vol.23
, pp. 71-75
-
-
Carney, D.N.1
-
97
-
-
0034177397
-
The taxanes: An update
-
Crown J, O ' Leary M. The taxanes: an update. Lancet 2000, 355, 1176-1178.
-
(2000)
Lancet
, vol.355
, pp. 1176-1178
-
-
Crown, J.1
O'Leary, M.2
-
98
-
-
27144472720
-
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
-
Uchino H, Matsumura Y, Negishi T, Koizumi F, Hayashi T, Honda T, Nishiyama N, Kataoka K, Naito S, Kakizoe T. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br. J. Cancer 2005, 93, 678-687.
-
(2005)
Br. J. Cancer
, vol.93
, pp. 678-687
-
-
Uchino, H.1
Matsumura, Y.2
Negishi, T.3
Koizumi, F.4
Hayashi, T.5
Honda, T.6
Nishiyama, N.7
Kataoka, K.8
Naito, S.9
Kakizoe, T.10
-
99
-
-
20444445144
-
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer
-
Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker Jr. J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65, 5317-5324.
-
(2005)
Cancer Res
, vol.65
, pp. 5317-5324
-
-
Kukowska-Latallo, J.F.1
Candido, K.A.2
Cao, Z.3
Nigavekar, S.S.4
Majoros, I.J.5
Thomas, T.P.6
Balogh, L.P.7
Khan, M.K.8
Baker, J.R.9
-
100
-
-
33846213522
-
Dendrimer-encapsulated camptothecins: Increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro
-
Morgan MT, Nakanishi Y, Kroll DJ, Griset AP, Carnahan MA, Wathier M, Oberlies NH, Manikumar G, Wani MC, Grinstaff MW. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res. 2006, 66, 11913-11921.
-
(2006)
Cancer Res
, vol.66
, pp. 11913-11921
-
-
Morgan, M.T.1
Nakanishi, Y.2
Kroll, D.J.3
Griset, A.P.4
Carnahan, M.A.5
Wathier, M.6
Oberlies, N.H.7
Manikumar, G.8
Wani, M.C.9
Grinstaff, M.W.10
-
101
-
-
1042302105
-
Dendrimers and protein cages as nanoparticles in drug delivery
-
Cloninger M. Dendrimers and protein cages as nanoparticles in drug delivery. Drug Discov. Today 2004, 9, 111-112.
-
(2004)
Drug Discov. Today
, vol.9
, pp. 111-112
-
-
Cloninger, M.1
-
102
-
-
0036899037
-
Biological applications of dendrimers
-
Cloninger MJ. Biological applications of dendrimers. Curr. Opin. Chem. Biol. 2002, 6, 742-748.
-
(2002)
Curr. Opin. Chem. Biol
, vol.6
, pp. 742-748
-
-
Cloninger, M.J.1
-
103
-
-
0033792661
-
Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle
-
Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. Mol. Pharmacol. 2000, 58, 1100-1108.
-
(2000)
Mol. Pharmacol
, vol.58
, pp. 1100-1108
-
-
Witvrouw, M.1
Fikkert, V.2
Pluymers, W.3
Matthews, B.4
Mardel, K.5
Schols, D.6
Raff, J.7
Debyser, Z.8
De Clercq, E.9
Holan, G.10
Pannecouque, C.11
-
104
-
-
27144506547
-
Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: An integrated parent-metabolite model
-
Ortega F, Quintana A, Suarez E, Lukas JC, Jauregizar N, de la Fuente L, Lucero ML, Gonzalo A, Orjales A, Calvo R. Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model. Pharm. Res. 2005, 22, 1769-1782.
-
(2005)
Pharm. Res
, vol.22
, pp. 1769-1782
-
-
Ortega, F.1
Quintana, A.2
Suarez, E.3
Lukas, J.C.4
Jauregizar, N.5
De La Fuente, L.6
Lucero, M.L.7
Gonzalo, A.8
Orjales, A.9
Calvo, R.10
-
105
-
-
24944531237
-
Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy
-
Majoros IJ, Thomas TP, Mehta CB, Baker Jr. J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 2005, 48, 5892-5899.
-
(2005)
J. Med. Chem
, vol.48
, pp. 5892-5899
-
-
Majoros, I.J.1
Thomas, T.P.2
Mehta, C.B.3
Baker, J.R.4
-
106
-
-
20144380223
-
Targeting and inhibition of cell growth by an engineered dendritic nanodevice
-
Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker Jr. J.R. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem. 2005, 48, 3729-3735.
-
(2005)
J. Med. Chem
, vol.48
, pp. 3729-3735
-
-
Thomas, T.P.1
Majoros, I.J.2
Kotlyar, A.3
Kukowska-Latallo, J.F.4
Bielinska, A.5
Myc, A.6
Baker, J.R.7
-
107
-
-
33644593095
-
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality
-
Majoros IJ, Myc A, Thomas T, Mehta CB, Baker Jr. J.R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006, 7, 572-579.
-
(2006)
Biomacromolecules
, vol.7
, pp. 572-579
-
-
Majoros, I.J.1
Myc, A.2
Thomas, T.3
Mehta, C.B.4
Baker, J.R.5
-
108
-
-
29744458148
-
Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates
-
Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker Jr. J.R. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem. Commun. 2005, 46, 5739-5741.
-
(2005)
Chem. Commun
, vol.46
, pp. 5739-5741
-
-
Shukla, R.1
Thomas, T.P.2
Peters, J.3
Kotlyar, A.4
Myc, A.5
Baker, J.R.6
-
109
-
-
0038714289
-
Endothelial signaling during development
-
Cleaver O, Melton DA. Endothelial signaling during development. Nat. Med. 2003, 9, 661-668.
-
(2003)
Nat. Med
, vol.9
, pp. 661-668
-
-
Cleaver, O.1
Melton, D.A.2
-
110
-
-
20344394447
-
Boron neutron capture therapy of cancer: Current status and future prospects
-
Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 2005, 11, 3987-4002.
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 3987-4002
-
-
Barth, R.F.1
Coderre, J.A.2
Vicente, M.G.3
Blue, T.E.4
-
111
-
-
33751151030
-
Synthesis of boron-rich lysine dendrimers as protein labels in electron microscopy
-
Qualmann B, Kessels MM, Musiol HJ, Sierralta WD, Jungblut PW, Moroder L. Synthesis of boron-rich lysine dendrimers as protein labels in electron microscopy. Angew. Chem. Int. Ed. 1996, 35, 909-911.
-
(1996)
Angew. Chem. Int. Ed
, vol.35
, pp. 909-911
-
-
Qualmann, B.1
Kessels, M.M.2
Musiol, H.J.3
Sierralta, W.D.4
Jungblut, P.W.5
Moroder, L.6
-
112
-
-
0027950222
-
Boronated starburst dendrimer monoclonal-antibody immu-noconjugates-evaluation as a potential delivery system for neutron-capture therapy
-
Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst dendrimer monoclonal-antibody immu-noconjugates-evaluation as a potential delivery system for neutron-capture therapy. Bioconj. Chem. 1994, 5, 58-66.
-
(1994)
Bioconj. Chem
, vol.5
, pp. 58-66
-
-
Barth, R.F.1
Adams, D.M.2
Soloway, A.H.3
Alam, F.4
Darby, M.V.5
-
113
-
-
0842285204
-
Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy
-
Wu G, Barth RF, Yang WL, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconj. Chem. 2004, 15, 185-194.
-
(2004)
Bioconj. Chem
, vol.15
, pp. 185-194
-
-
Wu, G.1
Barth, R.F.2
Yang, W.L.3
Chatterjee, M.4
Tjarks, W.5
Ciesielski, M.J.6
Fenstermaker, R.A.7
-
114
-
-
0038327602
-
In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells
-
Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Loser R, Jansen G, Peters GJ. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin. Cancer Res. 2003, 9, 1917-1926.
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 1917-1926
-
-
Wosikowski, K.1
Biedermann, E.2
Rattel, B.3
Breiter, N.4
Jank, P.5
Loser, R.6
Jansen, G.7
Peters, G.J.8
-
115
-
-
33750010294
-
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory defi cits induced by scopolamine in mice
-
Xie YL, Lu W, Jiang XG. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory defi cits induced by scopolamine in mice. Behav. Brain Res. 2006, 173, 76-84.
-
(2006)
Behav. Brain Res
, vol.173
, pp. 76-84
-
-
Xie, Y.L.1
Lu, W.2
Jiang, X.G.3
-
116
-
-
33947143588
-
Surfactant-polymer nanoparticles: A novel platform for sustained and enhanced cellular delivery of water-soluble molecules
-
Chavanpatil MD, Khdair A, Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm. Res. 2007, 24, 803-810.
-
(2007)
Pharm. Res
, vol.24
, pp. 803-810
-
-
Chavanpatil, M.D.1
Khdair, A.2
Panyam, J.3
-
117
-
-
24044459756
-
Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity
-
Hyung Park J, Kwon S, Lee M, Chung H, Kim JH, Kim YS, Park RW, Kim IS, Bong Seo S, Kwon IC, Young Jeong S. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials 2006, 27, 119-126.
-
(2006)
Biomaterials
, vol.27
, pp. 119-126
-
-
Hyung Park, J.1
Kwon, S.2
Lee, M.3
Chung, H.4
Kim, J.H.5
Kim, Y.S.6
Park, R.W.7
Kim, I.S.8
Bong Seo, S.9
Kwon, I.C.10
Young Jeong, S.11
-
118
-
-
33646886334
-
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
-
Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A, Felix R. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol. 2006, 78, 7-14.
-
(2006)
J. Neurooncol
, vol.78
, pp. 7-14
-
-
Jordan, A.1
Scholz, R.2
Maier-Hauff, K.3
Van Landeghem, F.K.4
Waldoefner, N.5
Teichgraeber, U.6
Pinkernelle, J.7
Bruhn, H.8
Neumann, F.9
Thiesen, B.10
Von Deimling, A.11
Felix, R.12
-
119
-
-
33749533577
-
Drug loaded magnetic nanoparticles for cancer therapy
-
Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C. Drug loaded magnetic nanoparticles for cancer therapy. J. Phys. Condens. Mat. 2006, 18, S2893-S2902.
-
(2006)
J. Phys. Condens. Mat
, vol.18
, pp. S2893-S2902
-
-
Jurgons, R.1
Seliger, C.2
Hilpert, A.3
Trahms, L.4
Odenbach, S.5
Alexiou, C.6
-
120
-
-
0345686712
-
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
-
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 2003, 100, 13549-13554.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 13549-13554
-
-
Hirsch, L.R.1
Stafford, R.J.2
Bankson, J.A.3
Sershen, S.R.4
Rivera, B.5
Price, R.E.6
Hazle, J.D.7
Halas, N.J.8
West, J.L.9
-
121
-
-
0038202316
-
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy
-
Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 2003, 125, 7860-7865.
-
(2003)
J. Am. Chem. Soc
, vol.125
, pp. 7860-7865
-
-
Roy, I.1
Ohulchanskyy, T.Y.2
Pudavar, H.E.3
Bergey, E.J.4
Oseroff, A.R.5
Morgan, J.6
Dougherty, T.J.7
Prasad, P.N.8
-
122
-
-
33646594749
-
A new class of silica cross-linked micellar core-shell nanoparticles
-
Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E. A new class of silica cross-linked micellar core-shell nanoparticles. J. Am. Chem. Soc. 2006, 128, 6447-6453.
-
(2006)
J. Am. Chem. Soc
, vol.128
, pp. 6447-6453
-
-
Huo, Q.1
Liu, J.2
Wang, L.Q.3
Jiang, Y.4
Lambert, T.N.5
Fang, E.6
-
123
-
-
84858828069
-
Carbon nanotubes in cancer therapy and drug delivery
-
Elhissi AM, Ahmed W, Hassan IU, Dhanak VR, D ' Emanuele A. Carbon nanotubes in cancer therapy and drug delivery. J. Drug Deliv. 2012, 837327.
-
J. Drug Deliv
, vol.2012
, pp. 837327
-
-
Elhissi, A.M.1
Ahmed, W.2
Hassan, I.U.3
Dhanak, V.R.4
D'Emanuele, A.5
-
124
-
-
84858834048
-
A new era of cancer treatment: Carbon nanotubes as drug delivery tools
-
Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int. J. Nanomed. 2011, 6, 2963-2979.
-
(2011)
Int. J. Nanomed
, vol.6
, pp. 2963-2979
-
-
Madani, S.Y.1
Naderi, N.2
Dissanayake, O.3
Tan, A.4
Seifalian, A.M.5
-
125
-
-
0342819025
-
Helical microtubules of graphitic carbon
-
Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354, 56-58.
-
(1991)
Nature
, vol.354
, pp. 56-58
-
-
Iijima, S.1
-
126
-
-
1642540193
-
Translocation of bioactive peptides across cell membranes by carbon nanotubes
-
Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 2004, 1, 16-17.
-
(2004)
Chem. Commun
, vol.1
, pp. 16-17
-
-
Pantarotto, D.1
Briand, J.P.2
Prato, M.3
Bianco, A.4
-
127
-
-
6044263759
-
Functionalized carbon nanotubes for plasmid DNA gene delivery
-
Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Ed. Engl. 2004, 43, 5242-5246.
-
(2004)
Angew. Chem. Int. Ed. Engl
, vol.43
, pp. 5242-5246
-
-
Pantarotto, D.1
Singh, R.2
McCarthy, D.3
Erhardt, M.4
Briand, J.P.5
Prato, M.6
Kostarelos, K.7
Bianco, A.8
-
129
-
-
50249159611
-
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device
-
Dhar S, Liu Z, Thomale J, Dai HJ, Lippard SJ. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J. Am. Chem. Soc. 2008, 130, 11467-11476.
-
(2008)
J. Am. Chem. Soc
, vol.130
, pp. 11467-11476
-
-
Dhar, S.1
Liu, Z.2
Thomale, J.3
Dai, H.J.4
Lippard, S.J.5
-
130
-
-
57549085002
-
Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery
-
Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. 2008, 130, 16778-16785.
-
(2008)
J. Am. Chem. Soc
, vol.130
, pp. 16778-16785
-
-
Chen, J.1
Chen, S.2
Zhao, X.3
Kuznetsova, L.V.4
Wong, S.S.5
Ojima, I.6
-
131
-
-
33745856990
-
Fullerene (C60) immunoconjugates: Interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody
-
Ashcroft JM, Tsyboulski DA, Hartman KB, Zakharian TY, Marks JW, Weisman RB, Rosenblum MG, Wilson LJ. Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody. Chem. Commun. 2006, 28, 3004-3006.
-
(2006)
Chem. Commun
, vol.28
, pp. 3004-3006
-
-
Ashcroft, J.M.1
Tsyboulski, D.A.2
Hartman, K.B.3
Zakharian, T.Y.4
Marks, J.W.5
Weisman, R.B.6
Rosenblum, M.G.7
Wilson, L.J.8
-
132
-
-
33748601861
-
Biomedical applications and potential health risks of nanomaterials: Molecular mechanisms
-
Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr. Mol. Med. 2006, 6, 651-663.
-
(2006)
Curr. Mol. Med
, vol.6
, pp. 651-663
-
-
Lanone, S.1
Boczkowski, J.2
-
133
-
-
34147160663
-
Cellular responses to nanoparticles: Target structures and mechanisms
-
Unfried K, Albrecht C, Klotz LO, Von Mikecz A, Grether-Beck S, Schins RPF. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 2007, 1, 52-71.
-
(2007)
Nanotoxicology
, vol.1
, pp. 52-71
-
-
Unfried, K.1
Albrecht, C.2
Klotz, L.O.3
Von Mikecz, A.4
Grether-Beck, S.5
Schins, R.P.F.6
-
134
-
-
34547690726
-
Immunological properties of engineered nanomaterials
-
Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478.
-
(2007)
Nat. Nanotechnol
, vol.2
, pp. 469-478
-
-
Dobrovolskaia, M.A.1
McNeil, S.E.2
-
135
-
-
38049162212
-
Engineered nanomaterials in soils and water: How do they behave and could they pose a risk to human health ?
-
Boxall AB, Tiede K, Chaudhry Q. Engineered nanomaterials in soils and water: how do they behave and could they pose a risk to human health ? Nanomedicine 2007, 2, 919-927.
-
(2007)
Nanomedicine
, vol.2
, pp. 919-927
-
-
Boxall, A.B.1
Tiede, K.2
Chaudhry, Q.3
-
136
-
-
31944451232
-
Toxic potential of materials at the nanolevel
-
Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627.
-
(2006)
Science
, vol.311
, pp. 622-627
-
-
Nel, A.1
Xia, T.2
Madler, L.3
Li, N.4
-
137
-
-
79951712963
-
Perspectives in nanomedicine-based research towards cancer therapies
-
Rane YM, Souto EB. Perspectives in nanomedicine-based research towards cancer therapies. Curr. Nanosci. 2011, 7, 142-152.
-
(2011)
Curr. Nanosci
, vol.7
, pp. 142-152
-
-
Rane, Y.M.1
Souto, E.B.2
-
139
-
-
78651240699
-
Nanotechnology and in situ remediation: A review of the benefi ts and potential risks
-
Karn B, Kuiken T, Otto M. Nanotechnology and in situ remediation: a review of the benefi ts and potential risks. Cien Saude Colet. 2011, 16, 165-178.
-
(2011)
Cien Saude Colet
, vol.16
, pp. 165-178
-
-
Karn, B.1
Kuiken, T.2
Otto, M.3
-
140
-
-
78650783860
-
Fate and transport of engineered nanomaterials in the environment
-
Lin D, Tian X, Wu F, Xing B. Fate and transport of engineered nanomaterials in the environment. J. Environ. Qual. 2010, 39, 1896-1908.
-
(2010)
J. Environ. Qual
, vol.39
, pp. 1896-1908
-
-
Lin, D.1
Tian, X.2
Wu, F.3
Xing, B.4
-
141
-
-
77949917110
-
Potential hazard of nanoparticles: From properties to biological and environmental effects
-
Kahru A, Savolainen K. Potential hazard of nanoparticles: from properties to biological and environmental effects. Toxicology 2010, 269, 89-91.
-
(2010)
Toxicology
, vol.269
, pp. 89-91
-
-
Kahru, A.1
Savolainen, K.2
-
142
-
-
46749153312
-
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study
-
Poland CA, Duffi n R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3, 423-428.
-
(2008)
Nat. Nanotechnol
, vol.3
, pp. 423-428
-
-
Poland, C.A.1
Duffi, N.R.2
Kinloch, I.3
Maynard, A.4
Wallace, W.A.5
Seaton, A.6
Stone, V.7
Brown, S.8
Macnee, W.9
Donaldson, K.10
-
143
-
-
68649099669
-
Analysis, behavior and ecotoxicity of carbon-based nanomaterials in the aquatic environment
-
Perez S, Farre M, Barcelo D. Analysis, behavior and ecotoxicity of carbon-based nanomaterials in the aquatic environment. Trends Anal. Chem. 2009, 28, 820-832.
-
(2009)
Trends Anal. Chem
, vol.28
, pp. 820-832
-
-
Perez, S.1
Farre, M.2
Barcelo, D.3
-
144
-
-
61349139614
-
Drug delivery and nanoparticles: Applications and hazards
-
De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3, 133-149.
-
(2008)
Int. J. Nanomed
, vol.3
, pp. 133-149
-
-
De Jong, W.H.1
Borm, P.J.2
-
145
-
-
33645744010
-
A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks
-
Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36, 189-217.
-
(2006)
Crit. Rev. Toxicol
, vol.36
, pp. 189-217
-
-
Lam, C.W.1
James, J.T.2
McCluskey, R.3
Arepalli, S.4
Hunter, R.L.5
-
146
-
-
1542726626
-
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation
-
Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 2004, 77, 126-134.
-
(2004)
Toxicol. Sci
, vol.77
, pp. 126-134
-
-
Lam, C.W.1
James, J.T.2
McCluskey, R.3
Hunter, R.L.4
-
147
-
-
25844464705
-
Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappa B in human keratinocytes
-
Manna SK, Sarkar S, Barr J, Wise K, Barrera EV, Jejelowo O, Rice-Ficht AC, Ramesh GT. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappa B in human keratinocytes. Nano Lett. 2005, 5, 1676-1684.
-
(2005)
Nano Lett
, vol.5
, pp. 1676-1684
-
-
Manna, S.K.1
Sarkar, S.2
Barr, J.3
Wise, K.4
Barrera, E.V.5
Jejelowo, O.6
Rice-Ficht, A.C.7
Ramesh, G.T.8
-
148
-
-
0942269167
-
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats
-
Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004, 77, 117-125.
-
(2004)
Toxicol. Sci
, vol.77
, pp. 117-125
-
-
Warheit, D.B.1
Laurence, B.R.2
Reed, K.L.3
Roach, D.H.4
Reynolds, G.A.5
Webb, T.R.6
-
149
-
-
70449556649
-
Inhaled carbon nanotubes reach the subpleural tissue in mice
-
Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW, Moss OR, Wong BA, Dodd DE, Andersen ME, Bonner JC. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 2009, 4, 747-751.
-
(2009)
Nat. Nanotechnol
, vol.4
, pp. 747-751
-
-
Ryman-Rasmussen, J.P.1
Cesta, M.F.2
Brody, A.R.3
Shipley-Phillips, J.K.4
Everitt, J.I.5
Tewksbury, E.W.6
Moss, O.R.7
Wong, B.A.8
Dodd, D.E.9
Andersen, M.E.10
Bonner, J.C.11
-
150
-
-
61549121705
-
Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma
-
Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA, Bonner JC. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am. J. Respir. Cell Mol. Biol. 2009, 40, 349-358.
-
(2009)
Am. J. Respir. Cell Mol. Biol
, vol.40
, pp. 349-358
-
-
Ryman-Rasmussen, J.P.1
Tewksbury, E.W.2
Moss, O.R.3
Cesta, M.F.4
Wong, B.A.5
Bonner, J.C.6
-
151
-
-
59949096454
-
Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats
-
Sakamoto Y, Nakae D, Fukumori N, Tayama K, Maekawa A, Imai K, Hirose A, Nishimura T, Ohashi N, Ogata A. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J. Toxicol. Sci. 2009, 34, 65-76.
-
(2009)
J. Toxicol. Sci
, vol.34
, pp. 65-76
-
-
Sakamoto, Y.1
Nakae, D.2
Fukumori, N.3
Tayama, K.4
Maekawa, A.5
Imai, K.6
Hirose, A.7
Nishimura, T.8
Ohashi, N.9
Ogata, A.10
-
152
-
-
33645674888
-
Solubilization, purification and functionalization of carbon nanotubes using polyoxometalate
-
Fei B, Lu HF, Hu ZG, Xin JH. Solubilization, purification and functionalization of carbon nanotubes using polyoxometalate. Nanotechnology 2006, 17, 1589-1593.
-
(2006)
Nanotechnology
, vol.17
, pp. 1589-1593
-
-
Fei, B.1
Lu, H.F.2
Hu, Z.G.3
Xin, J.H.4
-
153
-
-
84859727420
-
DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis
-
Bhattacharya S, Roxbury D, Gong X, Mukhopadhyay D, Jagota A. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. Nano Lett. 2012, 12, 1826-1830.
-
(2012)
Nano Lett
, vol.12
, pp. 1826-1830
-
-
Bhattacharya, S.1
Roxbury, D.2
Gong, X.3
Mukhopadhyay, D.4
Jagota, A.5
-
154
-
-
33745741441
-
Oops they did it again! Carbon nanotubes hoax scientists in viability assays
-
Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006, 6, 1261-1268.
-
(2006)
Nano Lett
, vol.6
, pp. 1261-1268
-
-
Worle-Knirsch, J.M.1
Pulskamp, K.2
Krug, H.F.3
-
155
-
-
60049097217
-
Aggregation and disaggregation of iron oxide nanoparticles: influence of particle concentration, pH and natural organic matter
-
Baalousha M. Aggregation and disaggregation of iron oxide nanoparticles: influence of particle concentration, pH and natural organic matter. Sci. Total Environ. 2009, 407, 2093-2101.
-
(2009)
Sci. Total Environ
, vol.407
, pp. 2093-2101
-
-
Baalousha, M.1
-
156
-
-
33947360667
-
In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line
-
Chang JS, Chang KL, Hwang DF, Kong ZL. In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 2007, 41, 2064-2068.
-
(2007)
Environ. Sci. Technol
, vol.41
, pp. 2064-2068
-
-
Chang, J.S.1
Chang, K.L.2
Hwang, D.F.3
Kong, Z.L.4
-
157
-
-
0023801420
-
Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver
-
Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988, 168, 297-301.
-
(1988)
Radiology
, vol.168
, pp. 297-301
-
-
Stark, D.D.1
Weissleder, R.2
Elizondo, G.3
Hahn, P.F.4
Saini, S.5
Todd, L.E.6
Wittenberg, J.7
Ferrucci, J.T.8
-
158
-
-
0025253906
-
Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging
-
Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990, 175, 494-498.
-
(1990)
Radiology
, vol.175
, pp. 494-498
-
-
Weissleder, R.1
Elizondo, G.2
Wittenberg, J.3
Lee, A.S.4
Josephson, L.5
Brady, T.J.6
-
159
-
-
32044451341
-
Toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors
-
Hardman RA. Toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 2006, 114, 165-172.
-
(2006)
Environ. Health Perspect
, vol.114
, pp. 165-172
-
-
Hardman, R.A.1
-
160
-
-
23044459574
-
Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots
-
Lovric J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 2005, 83, 377-385.
-
(2005)
J. Mol. Med
, vol.83
, pp. 377-385
-
-
Lovric, J.1
Bazzi, H.S.2
Cuie, Y.3
Fortin, G.R.A.4
Winnik, F.M.5
Maysinger, D.6
-
161
-
-
0034632937
-
125I-labelled polyamidoamine dendrimers in vivo
-
Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Rel. 2000, 68, 299-302.
-
(2000)
J. Control. Rel
, vol.68
, pp. 299-302
-
-
Malik, N.1
Wiwattanapatapee, R.2
Klopsch, R.3
Lorenz, K.4
Frey, H.5
Weener, J.W.6
Meijer, E.W.7
Paulus, W.8
Duncan, R.9
-
162
-
-
0029789793
-
Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
-
Plank C, Mechtler K, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 1996, 7, 1437-1446.
-
(1996)
Hum. Gene Ther
, vol.7
, pp. 1437-1446
-
-
Plank, C.1
Mechtler, K.2
Szoka, F.C.3
Wagner, E.4
-
163
-
-
84858042094
-
Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro
-
Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, De Paoli Lacerda SH, McNeil SE. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol. Pharm. 2012, 9, 382-393.
-
(2012)
Mol. Pharm
, vol.9
, pp. 382-393
-
-
Dobrovolskaia, M.A.1
Patri, A.K.2
Simak, J.3
Hall, J.B.4
Semberova, J.5
De Paoli Lacerda, S.H.6
McNeil, S.E.7
-
164
-
-
28744445460
-
Dendrimer biocompatibility and toxicity
-
Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 2005, 57, 2215-2237.
-
(2005)
Adv. Drug Deliv. Rev
, vol.57
, pp. 2215-2237
-
-
Duncan, R.1
Izzo, L.2
-
165
-
-
46449100402
-
The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers
-
Kaminskas LM, Boyd BJ, Karellas P, Krippner GY, Lessene R, Kelly B, Porter CJ. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol. Pharm. 2008, 5, 449-463.
-
(2008)
Mol. Pharm
, vol.5
, pp. 449-463
-
-
Kaminskas, L.M.1
Boyd, B.J.2
Karellas, P.3
Krippner, G.Y.4
Lessene, R.5
Kelly, B.6
Porter, C.J.7
-
166
-
-
65649151375
-
Effects of nanomaterial physicochemical properties on in vivo toxicity
-
Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61, 457-466.
-
(2009)
Adv. Drug Deliv. Rev
, vol.61
, pp. 457-466
-
-
Aillon, K.L.1
Xie, Y.2
El-Gendy, N.3
Berkland, C.J.4
Forrest, M.L.5
-
167
-
-
0035999704
-
Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation
-
Padilla De Jesus OL, Ihre HR, Gagne L, Frechet JM, Szoka FC Jr. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconj. Chem. 2002, 13, 453-461.
-
(2002)
Bioconj. Chem
, vol.13
, pp. 453-461
-
-
Padilla De Jesus, O.L.1
Ihre, H.R.2
Gagne, L.3
Frechet, J.M.4
Szoka, F.C.5
-
168
-
-
4043103282
-
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery
-
Chen HT, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc. 2004, 126, 10044-10048.
-
(2004)
J. Am. Chem. Soc
, vol.126
, pp. 10044-10048
-
-
Chen, H.T.1
Neerman, M.F.2
Parrish, A.R.3
Simanek, E.E.4
-
169
-
-
34548532823
-
Targeted delivery systems of small interfering RNA by systemic administration
-
Kawakami S, Hashida M. Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab. Pharmacokinet. 2007, 22, 142-151.
-
(2007)
Drug Metab. Pharmacokinet
, vol.22
, pp. 142-151
-
-
Kawakami, S.1
Hashida, M.2
-
170
-
-
16244362066
-
Cationic lipids enhance siRNA-mediated interferon response in mice
-
Ma Z, Li J, He F, Wilson A, Pitt B, Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 2005, 330, 755-759.
-
(2005)
Biochem. Biophys. Res. Commun
, vol.330
, pp. 755-759
-
-
Ma, Z.1
Li, J.2
He, F.3
Wilson, A.4
Pitt, B.5
Li, S.6
-
171
-
-
34248213490
-
Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity
-
Hollins AJ, Omidi Y, Benter IF, Akhtar S. Toxicogenomics of drug delivery systems: exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J. Drug Target. 2007, 15, 83-88.
-
(2007)
J. Drug Target
, vol.15
, pp. 83-88
-
-
Hollins, A.J.1
Omidi, Y.2
Benter, I.F.3
Akhtar, S.4
-
172
-
-
0031612974
-
The novel lipid delivery system of amphotericin B: Drug profile and relevance to clinical practice
-
Rust DM, Jameson G. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice. Oncol. Nurs. Forum. 1998, 25, 35-48.
-
(1998)
Oncol. Nurs. Forum
, vol.25
, pp. 35-48
-
-
Rust, D.M.1
Jameson, G.2
-
173
-
-
0032824375
-
Possibility of active targeting to tumor tissues with liposomes
-
Maruyama K, Ishida O, Takizawa T, Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv. Drug Deliv. Rev. 1999, 40, 89-102.
-
(1999)
Adv. Drug Deliv. Rev
, vol.40
, pp. 89-102
-
-
Maruyama, K.1
Ishida, O.2
Takizawa, T.3
Moribe, K.4
-
174
-
-
61649102498
-
Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine
-
Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, Larson SM, Wiesner U, Bradbury M. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2009, 9, 442-448.
-
(2009)
Nano Lett
, vol.9
, pp. 442-448
-
-
Burns, A.A.1
Vider, J.2
Ow, H.3
Herz, E.4
Penate-Medina, O.5
Baumgart, M.6
Larson, S.M.7
Wiesner, U.8
Bradbury, M.9
-
175
-
-
51049092308
-
Factors affecting the clearance and biodistribution of polymeric nanoparticles
-
Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 2008, 5, 505-515.
-
(2008)
Mol. Pharm
, vol.5
, pp. 505-515
-
-
Alexis, F.1
Pridgen, E.2
Molnar, L.K.3
Farokhzad, O.C.4
-
176
-
-
84857313332
-
influence of formulation variables on the biodistribution of multifunctional block copolymer micelles
-
Fonge H, Huang H, Scollard D, Reilly RM, Allen C. influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. J. Control. Rel. 2012, 157, 366-374.
-
(2012)
J. Control. Rel
, vol.157
, pp. 366-374
-
-
Fonge, H.1
Huang, H.2
Scollard, D.3
Reilly, R.M.4
Allen, C.5
-
177
-
-
83555166219
-
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
-
Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6, 815-823.
-
(2011)
Nat. Nanotechnol
, vol.6
, pp. 815-823
-
-
Cabral, H.1
Matsumoto, Y.2
Mizuno, K.3
Chen, Q.4
Murakami, M.5
Kimura, M.6
Terada, Y.7
Kano, M.R.8
Miyazono, K.9
Uesaka, M.10
Nishiyama, N.11
Kataoka, K.12
-
178
-
-
55949126429
-
Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats
-
Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008, 3, 703-717.
-
(2008)
Nanomedicine
, vol.3
, pp. 703-717
-
-
Longmire, M.1
Choyke, P.L.2
Kobayashi, H.3
-
179
-
-
81255143243
-
Improving delivery and effi cacy of nanomedicines in solid tumors: Role of tumor priming
-
Wang J, Lu Z, Gao Y, Wientjes MG, Au JLS. Improving delivery and effi cacy of nanomedicines in solid tumors: role of tumor priming. Nanomedicine 2011, 6, 1605-1620.
-
(2011)
Nanomedicine
, vol.6
, pp. 1605-1620
-
-
Wang, J.1
Lu, Z.2
Gao, Y.3
Wientjes, M.G.4
Au, J.L.S.5
-
181
-
-
19944433260
-
Quantum dots for live cells, in vivo imaging, and diagnostics
-
Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307, 538-544.
-
(2005)
Science
, vol.307
, pp. 538-544
-
-
Michalet, X.1
Pinaud, F.F.2
Bentolila, L.A.3
Tsay, J.M.4
Doose, S.5
Li, J.J.6
Sundaresan, G.7
Wu, A.M.8
Gambhir, S.S.9
Weiss, S.10
-
182
-
-
3543022686
-
In vivo cancer targeting and imaging with semiconductor quantum dots
-
Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22, 969-976.
-
(2004)
Nat. Biotechnol
, vol.22
, pp. 969-976
-
-
Gao, X.1
Cui, Y.2
Levenson, R.M.3
Chung, L.W.4
Nie, S.5
-
183
-
-
38049104255
-
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
-
McDevitt MR, Chattopadhyay D, Jaggi JS, Finn RD, Zanzonico PB, Villa C, Rey D, Mendenhall J, Batt CA, Njardarson JT, Scheinberg DA. PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS One 2007, 2, e907.
-
(2007)
PLoS One
, vol.2
, pp. e907
-
-
McDevitt, M.R.1
Chattopadhyay, D.2
Jaggi, J.S.3
Finn, R.D.4
Zanzonico, P.B.5
Villa, C.6
Rey, D.7
Mendenhall, J.8
Batt, C.A.9
Njardarson, J.T.10
Scheinberg, D.A.11
-
184
-
-
33644748178
-
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers
-
Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA 2006, 103, 3357-3362.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 3357-3362
-
-
Singh, R.1
Pantarotto, D.2
Lacerda, L.3
Pastorin, G.4
Klumpp, C.5
Prato, M.6
Bianco, A.7
Kostarelos, K.8
-
185
-
-
73849140878
-
Design considerations for tumour-targeted nanoparticles
-
Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV. Design considerations for tumour-targeted nanoparticles. Nat. Nanotechnol. 2010, 5, 42-47.
-
(2010)
Nat. Nanotechnol
, vol.5
, pp. 42-47
-
-
Choi, H.S.1
Liu, W.2
Liu, F.3
Nasr, K.4
Misra, P.5
Bawendi, M.G.6
Frangioni, J.V.7
-
186
-
-
67349281952
-
Protracted elimination of gold nanoparticles from mouse liver
-
Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomed. Nanotechnol. 2009, 5, 162-169.
-
(2009)
Nanomed. Nanotechnol
, vol.5
, pp. 162-169
-
-
Sadauskas, E.1
Danscher, G.2
Stoltenberg, M.3
Vogel, U.4
Larsen, A.5
Wallin, H.6
-
187
-
-
68249138692
-
Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers
-
Kaminskas LM, Wu Z, Barlow N, Krippner GY, Boyd BJ, Porter CJH. Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers. J. Pharm. Sci. 2009, 98, 3871-3875.
-
(2009)
J. Pharm. Sci
, vol.98
, pp. 3871-3875
-
-
Kaminskas, L.M.1
Wu, Z.2
Barlow, N.3
Krippner, G.Y.4
Boyd, B.J.5
Porter, C.J.H.6
-
188
-
-
38849152834
-
Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion
-
Lacerda L, Soundararajan A, Singh R, Pastorin G, Al-Jamal KT, Turton J, Frederik P, Herrero MA, Bao SLA, Emfi etzoglou D, Mather S, Phillips WT, Prato M, Bianco A, Goins B, Kostarelos K. Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion. Adv. Mater. 2008, 20, 225-230.
-
(2008)
Adv. Mater
, vol.20
, pp. 225-230
-
-
Lacerda, L.1
Soundararajan, A.2
Singh, R.3
Pastorin, G.4
Al-Jamal, K.T.5
Turton, J.6
Frederik, P.7
Herrero, M.A.8
Bao, S.L.A.9
Emfi etzoglou, D.10
Mather, S.11
Phillips, W.T.12
Prato, M.13
Bianco, A.14
Goins, B.15
Kostarelos, K.16
-
189
-
-
49749128832
-
Carbon-nanotube shape and individualization critical for renal excretion
-
Lacerda L, Herrero MA, Venner K, Bianco A, Prato M, Kostarelos K. Carbon-nanotube shape and individualization critical for renal excretion. Small 2008, 4, 1130-1132.
-
(2008)
Small
, vol.4
, pp. 1130-1132
-
-
Lacerda, L.1
Herrero, M.A.2
Venner, K.3
Bianco, A.4
Prato, M.5
Kostarelos, K.6
-
190
-
-
65249178345
-
Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery
-
Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2, 85-120.
-
(2009)
Nano Res
, vol.2
, pp. 85-120
-
-
Liu, Z.1
Tabakman, S.2
Welsher, K.3
Dai, H.4
-
191
-
-
34249663107
-
Translocation and fate of multi-walled carbon nanotubes in vivo
-
Deng X, Jia G, Wang H, Sun H, Wang X, Yang S, Wang T, Liu Y. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 2007, 45, 1419-1424.
-
(2007)
Carbon
, vol.45
, pp. 1419-1424
-
-
Deng, X.1
Jia, G.2
Wang, H.3
Sun, H.4
Wang, X.5
Yang, S.6
Wang, T.7
Liu, Y.8
-
192
-
-
77955459129
-
Paradoxical glomerular filtration of carbon nanotubes
-
Ruggiero A, Villa CH, Bander E, Rey DA, Bergkvist M, Batt CA, Manova-Todorova K, Deen WM, Scheinberg DA, McDevitt MR. Paradoxical glomerular filtration of carbon nanotubes. Proc. Natl. Acad. Sci. USA 2010, 107, 12369-12374.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 12369-12374
-
-
Ruggiero, A.1
Villa, C.H.2
Bander, E.3
Rey, D.A.4
Bergkvist, M.5
Batt, C.A.6
Manova-Todorova, K.7
Deen, W.M.8
Scheinberg, D.A.9
McDevitt, M.R.10
-
193
-
-
77649146256
-
In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles
-
Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, Prasad PN. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4, 699-708.
-
(2010)
ACS Nano
, vol.4
, pp. 699-708
-
-
Kumar, R.1
Roy, I.2
Ohulchanskky, T.Y.3
Vathy, L.A.4
Bergey, E.J.5
Sajjad, M.6
Prasad, P.N.7
-
194
-
-
77955613395
-
Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals
-
Lu J, Liong M, Li ZX, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6, 1794-1805.
-
(2010)
Small
, vol.6
, pp. 1794-1805
-
-
Lu, J.1
Liong, M.2
Li, Z.X.3
Zink, J.I.4
Tamanoi, F.5
-
195
-
-
77953020259
-
Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles
-
Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JAA, Mou CY, Lo LW. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 2010, 31, 5564-5574.
-
(2010)
Biomaterials
, vol.31
, pp. 5564-5574
-
-
Souris, J.S.1
Lee, C.H.2
Cheng, S.H.3
Chen, C.T.4
Yang, C.S.5
Ho, J.A.A.6
Mou, C.Y.7
Lo, L.W.8
-
196
-
-
43449094338
-
Is personalized medicine finally arriving ?
-
Allison M. Is personalized medicine finally arriving ? Nat. Biotechnol. 2008, 26, 509-517.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 509-517
-
-
Allison, M.1
-
197
-
-
84945219643
-
-
Dasgupta A, Eds., Humana Press: Totowa, NJ
-
Wong SHY. Pharmacogenomics and Personalized Medicine. Handbook of Drug Monitoring Methods, Dasgupta A, Eds., Humana Press: Totowa, NJ, 2008, pp. 211-223.
-
(2008)
Pharmacogenomics and Personalized Medicine. Handbook of Drug Monitoring Methods
, pp. 211-223
-
-
Shy, W.1
-
198
-
-
0036599469
-
Encoding microcarriers: Present and future technologies
-
Braeckmans K, De Smedt SC, Leblans M, Pauwels R, Demeester J. Encoding microcarriers: present and future technologies. Nat. Rev. Drug Discov. 2002, 1, 447-456.
-
(2002)
Nat. Rev. Drug Discov
, vol.1
, pp. 447-456
-
-
Braeckmans, K.1
De Smedt, S.C.2
Leblans, M.3
Pauwels, R.4
Demeester, J.5
-
199
-
-
0037421590
-
Pharmacogenomics-drug disposition, drug targets, and side effects
-
Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N. Engl. J. Med. 2003, 348, 538-549.
-
(2003)
N. Engl. J. Med
, vol.348
, pp. 538-549
-
-
Evans, W.E.1
McLeod, H.L.2
-
201
-
-
0036527775
-
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
-
Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 2002, 1, 287-299.
-
(2002)
Nat. Rev. Drug Discov
, vol.1
, pp. 287-299
-
-
Johnstone, R.W.1
-
202
-
-
77951602981
-
The past, present and future of pharmacoepigenomics
-
Ingelman-Sundberg M, Gomez A. The past, present and future of pharmacoepigenomics. Pharmacogenomics 2010, 11, 625-627.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 625-627
-
-
Ingelman-Sundberg, M.1
Gomez, A.2
-
203
-
-
39649124023
-
Array-based DNA diagnostics: Let the revolution begin
-
Beaudet AL, Belmont JW. Array-based DNA diagnostics: let the revolution begin. Annu. Rev. Med. 2008, 59, 113-129.
-
(2008)
Annu. Rev. Med
, vol.59
, pp. 113-129
-
-
Beaudet, A.L.1
Belmont, J.W.2
-
204
-
-
67651240453
-
Personalized clinical laboratory diagnostics
-
Kewal KJ. Personalized clinical laboratory diagnostics. Adv. Clin. Chem. 2009, 47, 95-119.
-
(2009)
Adv. Clin. Chem
, vol.47
, pp. 95-119
-
-
Kewal, K.J.1
-
205
-
-
0032840529
-
P-glycoprotein-mediated resistance to chemotherapy in cancer cells: Using recombinant cytosolic domains to establish structure-function relationships
-
Di Pietro A, Dayan G, Conseil G, Steinfels E, Krell T, Trompier D, Baubichon-Cortay H, Jault J. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships. Braz. J. Med. Biol. Res. 1999, 32, 925-939.
-
(1999)
Braz. J. Med. Biol. Res
, vol.32
, pp. 925-939
-
-
Di Pietro, A.1
Dayan, G.2
Conseil, G.3
Steinfels, E.4
Krell, T.5
Trompier, D.6
Baubichon-Cortay, H.7
Jault, J.8
-
206
-
-
0027095653
-
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
-
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258, 1650-1654.
-
(1992)
Science
, vol.258
, pp. 1650-1654
-
-
Cole, S.P.1
Bhardwaj, G.2
Gerlach, J.H.3
Mackie, J.E.4
Grant, C.E.5
Almquist, K.C.6
Stewart, A.J.7
Kurz, E.U.8
Duncan, A.M.9
Deeley, R.G.10
-
207
-
-
13044249156
-
A multidrug resistance transporter from human MCF-7 breast cancer cells
-
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 1998, 95, 15665-15670.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 15665-15670
-
-
Doyle, L.A.1
Yang, W.2
Abruzzo, L.V.3
Krogmann, T.4
Gao, Y.5
Rishi, A.K.6
Ross, D.D.7
-
208
-
-
0344142519
-
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
-
Minko T, Kopeckova P, Kopecek J. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J. Control. Rel. 1999, 59, 133-148.
-
(1999)
J. Control. Rel
, vol.59
, pp. 133-148
-
-
Minko, T.1
Kopeckova, P.2
Kopecek, J.3
-
209
-
-
0032580444
-
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
-
Omelyanenko V, Kopeckova P, Gentry C, Kopecek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Control. Rel. 1998, 53, 25-37.
-
(1998)
J. Control. Rel
, vol.53
, pp. 25-37
-
-
Omelyanenko, V.1
Kopeckova, P.2
Gentry, C.3
Kopecek, J.4
-
210
-
-
8244254377
-
Improvements in survival and clinical benefi t with gemcitabine as fi rst-line therapy for patients with advanced pancreas cancer: A randomized trial
-
Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD. Improvements in survival and clinical benefi t with gemcitabine as fi rst-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 1997, 15, 2403-2413.
-
(1997)
J. Clin. Oncol
, vol.15
, pp. 2403-2413
-
-
Burris, H.A.1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
Cripps, M.C.7
Portenoy, R.K.8
Storniolo, A.M.9
Tarassoff, P.10
Nelson, R.11
Dorr, F.A.12
Stephens, C.D.13
Von Hoff, D.D.14
-
211
-
-
8944261362
-
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
-
Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann. Oncol. 1996, 7, 347-353.
-
(1996)
Ann. Oncol
, vol.7
, pp. 347-353
-
-
Rothenberg, M.L.1
Moore, M.J.2
Cripps, M.C.3
Andersen, J.S.4
Portenoy, R.K.5
Burris, H.A.6
Green, M.R.7
Tarassoff, P.G.8
Brown, T.D.9
Casper, E.S.10
Storniolo, A.M.11
Von Hoff, D.D.12
-
212
-
-
0027993707
-
Effi cacy and safety profi le of gemcitabine in nonsmall-cell lung cancer: A phase II study
-
Abratt RP, Bezwoda WR, Falkson G, Goedhals L, Hacking D, Rugg TA. Effi cacy and safety profi le of gemcitabine in nonsmall-cell lung cancer: a phase II study. J. Clin. Oncol. 1994, 12, 1535-1540.
-
(1994)
J. Clin. Oncol
, vol.12
, pp. 1535-1540
-
-
Abratt, R.P.1
Bezwoda, W.R.2
Falkson, G.3
Goedhals, L.4
Hacking, D.5
Rugg, T.A.6
-
213
-
-
0035165047
-
Gemcitabine: Progress in the treatment of pancreatic cancer
-
Heinemann V. Gemcitabine: progress in the treatment of pancreatic cancer. Oncology 2001, 60, 8-18.
-
(2001)
Oncology
, vol.60
, pp. 8-18
-
-
Heinemann, V.1
-
214
-
-
0036462584
-
Determinants of resistance to 2 ' ,2 '-difl uorodeoxycytidine (gemcitabine)
-
Bergman AM, Pinedo HM, Peters GJ. Determinants of resistance to 2 ' ,2 '-difl uorodeoxycytidine (gemcitabine). Drug Resist. Updat. 2002, 5, 19-33.
-
(2002)
Drug Resist. Updat
, vol.5
, pp. 19-33
-
-
Bergman, A.M.1
Pinedo, H.M.2
Peters, G.J.3
-
215
-
-
27144524050
-
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant
-
Bergman AM, Eijk PP, Ruiz van Haperen VW, Smid K, Veerman G, Hubeek I, van den Ijssel P, Ylstra B, Peters GJ. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Cancer Res. 2005, 65, 9510-9516.
-
(2005)
Cancer Res
, vol.65
, pp. 9510-9516
-
-
Bergman, A.M.1
Eijk, P.P.2
Ruiz Van Haperen, V.W.3
Smid, K.4
Veerman, G.5
Hubeek, I.6
Van Den Ijssel, P.7
Ylstra, B.8
Peters, G.J.9
-
216
-
-
53449098390
-
Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fl uoropyrimidine-based chemotherapy: Evidence from 24 studies
-
Qiu LX, Tang QY, Bai JL, Qian XP, Li RT, Liu BR, Zheng MH. Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fl uoropyrimidine-based chemotherapy: evidence from 24 studies. Int. J. Cancer 2008, 123, 2384-2389.
-
(2008)
Int. J. Cancer
, vol.123
, pp. 2384-2389
-
-
Qiu, L.X.1
Tang, Q.Y.2
Bai, J.L.3
Qian, X.P.4
Li, R.T.5
Liu, B.R.6
Zheng, M.H.7
-
217
-
-
33846178254
-
Squalenoyl nanomedicines as potential therapeutics
-
Couvreur P, Stella B, Reddy LH, Hillaireau H, Dubernet C, Desmaele D, Lepetre-Mouelhi S, Rocco F, Dereuddre-Bosquet N, Clayette P, Rosilio V, Marsaud V, Renoir JM, Cattel L. Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 2006, 6, 2544-2548.
-
(2006)
Nano Lett
, vol.6
, pp. 2544-2548
-
-
Couvreur, P.1
Stella, B.2
Reddy, L.H.3
Hillaireau, H.4
Dubernet, C.5
Desmaele, D.6
Lepetre-Mouelhi, S.7
Rocco, F.8
Dereuddre-Bosquet, N.9
Clayette, P.10
Rosilio, V.11
Marsaud, V.12
Renoir, J.M.13
Cattel, L.14
-
218
-
-
39449128320
-
Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue
-
Couvreur P, Reddy LH, Mangenot S, Poupaert JH, Desmaele D, Lepetre-Mouelhi S, Pili B, Bourgaux C, Amenitsch H, Ollivon M. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small 2008, 4, 247-253.
-
(2008)
Small
, vol.4
, pp. 247-253
-
-
Couvreur, P.1
Reddy, L.H.2
Mangenot, S.3
Poupaert, J.H.4
Desmaele, D.5
Lepetre-Mouelhi, S.6
Pili, B.7
Bourgaux, C.8
Amenitsch, H.9
Ollivon, M.10
-
219
-
-
82255175232
-
Squalenoyl gemcitabine nanomedicine overcomes the low effi cacy of gemcitabine therapy in pancreatic cancer
-
Réjiba S, Reddy LH, Bigand C, Parmentier C, Couvreur P, Hajri A. Squalenoyl gemcitabine nanomedicine overcomes the low effi cacy of gemcitabine therapy in pancreatic cancer. Nanomed. Nanotechnol. 2011, 7, 841-849.
-
(2011)
Nanomed. Nanotechnol
, vol.7
, pp. 841-849
-
-
Réjiba, S.1
Reddy, L.H.2
Bigand, C.3
Parmentier, C.4
Couvreur, P.5
Hajri, A.6
-
220
-
-
77950160186
-
P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells
-
Li RB, Wu R, Zhao L, Wu MH, Yang L, Zou HF. P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nano 2010, 4, 1399-1408.
-
(2010)
ACS Nano
, vol.4
, pp. 1399-1408
-
-
Li, R.B.1
Wu, R.2
Zhao, L.3
Wu, M.H.4
Yang, L.5
Zou, H.F.6
-
221
-
-
49749101644
-
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifi ers
-
Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifi ers. J. Control. Rel. 2008, 130, 98-106.
-
(2008)
J. Control. Rel
, vol.130
, pp. 98-106
-
-
Batrakova, E.V.1
Kabanov, A.V.2
-
222
-
-
0142010619
-
Sensitization of cells overexpressing multidrugresistant proteins by Pluronic P85
-
Batrakova EV, Li S, Alakhov VY, Elmquist WF, Miller DW, Kabanov AV. Sensitization of cells overexpressing multidrugresistant proteins by Pluronic P85. Pharm. Res. 2003, 20, 1581-1590.
-
(2003)
Pharm. Res
, vol.20
, pp. 1581-1590
-
-
Batrakova, E.V.1
Li, S.2
Alakhov, V.Y.3
Elmquist, W.F.4
Miller, D.W.5
Kabanov, A.V.6
-
223
-
-
0035556313
-
Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: Selective energy depletion
-
Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion. Br. J. Cancer 2001, 85, 1987-1997.
-
(2001)
Br. J. Cancer
, vol.85
, pp. 1987-1997
-
-
Batrakova, E.V.1
Li, S.2
Elmquist, W.F.3
Miller, D.W.4
Alakhov, V.Y.5
Kabanov, A.V.6
-
224
-
-
0141955916
-
An essential relationship between ATP depletion and chemosensitizing activity of pluronic((R)) block copolymers
-
Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of pluronic((R)) block copolymers. J. Control. Rel. 2003, 91, 75-83.
-
(2003)
J. Control. Rel
, vol.91
, pp. 75-83
-
-
Kabanov, A.V.1
Batrakova, E.V.2
Alakhov, V.Y.3
-
225
-
-
34250379774
-
Radical nanomedicine
-
Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA. Radical nanomedicine. Nanomedicine 2006, 1, 399-412.
-
(2006)
Nanomedicine
, vol.1
, pp. 399-412
-
-
Rzigalinski, B.A.1
Meehan, K.2
Davis, R.M.3
Xu, Y.4
Miles, W.C.5
Cohen, C.A.6
-
226
-
-
37149036573
-
Treatment of neuro-degenerative disorders with radical nanomedicine
-
Singh N, Cohen CA, Rzigalinski BA. Treatment of neuro-degenerative disorders with radical nanomedicine. Ann. NY Acad. Sci. 2007, 1122, 219-230.
-
(2007)
Ann. NY Acad. Sci
, vol.1122
, pp. 219-230
-
-
Singh, N.1
Cohen, C.A.2
Rzigalinski, B.A.3
|